Parc Taulí begins a clinical study to test a new oncology drug in humans for the first time

by Instituto de Investigación e Innovación Parc Taulí

The study will evaluate the safety and efficacy of the molecule IMP1734, a selective inhibitor that blocks a key enzyme for DNA repair in cancer cells.

Read more

A pioneering study reveals new genetic mechanisms involved in rare head and neck tumours

by CNIO - Centro Nacional de Investigaciones Oncológicas

The team at the National Cancer Research Centre (CNIO), a world leader in paragangliomas and pheochromocytomas, is forging new pathways for the early diagnosis and personalised treatment of these canc...

Read more

Científicos del IUOPA de la Universidad de Oviedo descubren una nueva diana inmunológica clave en la leucemia más común en adultos

by Universidad de Oviedo

El Grupo de Inmunología Tumoral de la institución académica asturiana identifica una proteína con potencial terapéutico y pronóstico en la leucemia linfática crónica

Read more

Seeds of Metastasis Identified: A New Target to Prevent Breast Cancer Metastasis Before It Emerges

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The journal Cancer Cell has published a study led by the Hospital del Mar Research Institute, together with researchers from GEICAM, identifying malignant cells carrying the TIM-3 protein as a central...

Read more

A Device That Improves the Experience of Patients With Multiple Myeloma, Assessed in a Study With Participation From IDIVAL

by Instituto de Investigación Marqués de Valdecilla

Nurses Nuria Sánchez and Paula Calvo, from the Clinical Trials Unit of the Marqués de Valdecilla University Hospital (HUMV/IDIVAL), have participated in an international study conducted within the f...

Read more

Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine

by Thermo Fisher Scientific

New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results

Read more

How do our defenses help eliminate cancer? The key role of NK cells in antibody therapies

by CIC bioGUNE

The main players in this story are NK cells (short for natural killer), a type of white blood cell that patrols the body in search of abnormal cells. These cells recognize antibodies bound to tumor ce...

Read more

El proyecto internacional AIDA presenta un sistema de IA capaz de personalizar y optimizar el tratamiento contra Helicobacter pylori, la bacteria más comúnmente asociada al cáncer gástrico

by INCLIVA

AIDA (An Artificially Intelligent Diagnostic Assistant for gastric inflammation) es una iniciativa europea de investigación e innovación financiada por la Unión Europea que busca transformar el abo...

Read more

Un proyecto del Cima Universidad de Navarra, seleccionado por el Consejo Europeo de Investigación (ERC) para impulsar una nueva terapia de RNA para el cáncer colorrectal

by CIMA - Centro de Investigación Médica Aplicada

El equipo desarrollará una terapia basada en ARN, diseñada para inhibir específicamente la molécula de ARN largo no codificante (lncRNA). El objetivo es frenar el crecimiento del tumor y abrir nue...

Read more

New study validates the prognostic value of the HER2DX test in HER2-positive breast cancer

by Fundació Clínic per a la Recerca Biomèdica

The study demonstrates that incorporating the HER2DX genomic test—developed by Reveal Genomics and capable of capturing both clinical and biological factors—enables better risk stratification and ...

Read more

New clinical trial targets the most common form of skin cancer with a compound based on CNIO discoveries

by CNIO - Centro Nacional de Investigaciones Oncológicas

Highlight Therapeutics and CNIO are collaborating to proof BO-112 effectiveness against the most common form of skin cancer, which is linked to sun exposure and is on the rise.

Read more

Researchers at IBS.GRANADA are developing compounds with therapeutic potential against triple-negative breast cancer.

by Instituto de Investigación Biosanitaria - Ibs Granada

The study, published in the journal Bioorganic Chemistry, identifies molecules capable of blocking a key interaction in the progression of this type of tumor.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream